Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Gettinger, Scott N, Dr, Bazhenova, Lyudmila A, Prof, Langer, Corey J, Prof, Salgia, Ravi, Prof, Gold, Kathryn A, MD, Rosell, Rafael, Prof, Shaw, Alice T, MD, Weiss, Glen J, MD, Tugnait, Meera, PhD, Narasimhan, Narayana I, PhD, Dorer, David J, PhD, Kerstein, David, MD, Rivera, Victor M, PhD, Clackson, Timothy, PhD, Haluska, Frank G, MD, Camidge, David Ross, Prof
Published in The lancet oncology (01.12.2016)
Published in The lancet oncology (01.12.2016)
Get full text
Journal Article
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
Cortes, Jorge E, Kantarjian, Hagop, Shah, Neil P, Bixby, Dale, Mauro, Michael J, Flinn, Ian, O'Hare, Thomas, Hu, Simin, Narasimhan, Narayana I, Rivera, Victor M, Clackson, Tim, Turner, Christopher D, Haluska, Frank G, Druker, Brian J, Deininger, Michael W.N, Talpaz, Moshe
Published in The New England journal of medicine (29.11.2012)
Published in The New England journal of medicine (29.11.2012)
Get full text
Journal Article
Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma
Oza, Amit M, Pignata, Sandro, Poveda, Andres, McCormack, Mary, Clamp, Andrew, Schwartz, Benjamin, Cheng, Jonathan, Li, Xiaoyun, Campbell, Kristy, Dodion, Pierre, Haluska, Frank G
Published in Journal of clinical oncology (01.11.2015)
Published in Journal of clinical oncology (01.11.2015)
Get full text
Journal Article
Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
DEMETRI, George D, CHAWLA, Sant P, REICHARDT, Peter, BOMPAS, Emmanuelle, ALCINDOR, Thierry, RUSHING, Daniel, YANG SONG, LEE, Ruey-Min, EBBINGHAUS, Scot, EID, Joseph E, LOEWY, John W, HALUSKA, Frank G, RAY-COQUARD, Isabelle, DODION, Pierre F, BLAY, Jean-Yves, LE CESNE, Axel, STADDON, Arthur P, MILHEM, Mohammed M, PENEL, Nicolas, RIEDEL, Richard F, BUI-NGUYEN, Binh, CRANMER, Lee D
Published in Journal of clinical oncology (01.07.2013)
Published in Journal of clinical oncology (01.07.2013)
Get full text
Journal Article
Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group
BEDIKIAN, Agop Y, MILLWARD, Michael, KIRKWOOD, John M, HALUSKA, Frank G, PEHAMBERGER, Hubert, CORNY, Robert, GORE, Martin, TREFZER, Uwe, PAVLICK, Anna C, DECONTI, Ronald, HERSH, Evan M, HERSEY, Peter
Published in Journal of clinical oncology (10.10.2006)
Published in Journal of clinical oncology (10.10.2006)
Get full text
Journal Article
Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
CHAWLA, Sant P, STADDON, Arthur P, RIVERA, Victor M, CLACKSON, Tim, LOEWY, John W, HALUSKA, Frank G, DEMETRI, George D, BAKER, Laurence H, SCHUETZE, Scott M, TOLCHER, Anthony W, D'AMATO, Gina Z, BLAY, Jean-Yves, MITA, Monica M, SANKHALA, Kamalesh K, BERK, Lori
Published in Journal of clinical oncology (01.01.2012)
Published in Journal of clinical oncology (01.01.2012)
Get full text
Journal Article
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
Hodi, F. Stephen, Butler, Marcus, Oble, Darryl A, Seiden, Michael V, Haluska, Frank G, Kruse, Andrea, MacRae, Suzanne, Nelson, Marybeth, Canning, Christine, Lowy, Israel, Korman, Alan, Lautz, David, Russell, Sara, Jaklitsch, Michael T, Ramaiya, Nikhil, Chen, Teresa C, Neuberg, Donna, Allison, James P, Mihm, Martin C, Dranoff, Glenn
Published in Proceedings of the National Academy of Sciences - PNAS (26.02.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (26.02.2008)
Get full text
Journal Article
Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma
Tsao, Hensin, Yang, Guang, Goel, Vikas, Wu, Heng, Haluska, Frank G.
Published in Journal of investigative dermatology (01.02.2004)
Published in Journal of investigative dermatology (01.02.2004)
Get full text
Journal Article
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Lynch, Thomas J, Bell, Daphne W, Sordella, Raffaella, Gurubhagavatula, Sarada, Okimoto, Ross A, Brannigan, Brian W, Harris, Patricia L, Haserlat, Sara M, Supko, Jeffrey G, Haluska, Frank G, Louis, David N, Christiani, David C, Settleman, Jeff, Haber, Daniel A
Published in The New England journal of medicine (20.05.2004)
Published in The New England journal of medicine (20.05.2004)
Get full text
Journal Article
Genetic Alterations in Signaling Pathways in Melanoma
Haluska, Frank G, Tsao, Hensin, Wu, Helen, Haluska, Frank S, Lazar, Alexander, Goel, Vikas
Published in Clinical cancer research (01.04.2006)
Published in Clinical cancer research (01.04.2006)
Get full text
Journal Article
Biologic Activity of Cytotoxic T Lymphocyte-Associated Antigen 4 Antibody Blockade in Previously Vaccinated Metastatic Melanoma and Ovarian Carcinoma Patients
Hodi, F. Stephen, Mihm, Martin C., Soiffer, Robert J., Haluska, Frank G., Butler, Marcus, Seiden, Michael V., Davis, Thomas, Henry-Spires, Rochele, MacRae, Suzanne, Willman, Ann, Padera, Robert, Jaklitsch, Michael T., Shankar, Sridhar, Chen, Teresa C., Korman, Alan, Allison, James P., Dranoff, Glenn
Published in Proceedings of the National Academy of Sciences - PNAS (15.04.2003)
Published in Proceedings of the National Academy of Sciences - PNAS (15.04.2003)
Get full text
Journal Article
Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma
MITCHELL, Malcolm S, ABRAMS, Judith, JAKOWATZ, James G, DAS GUPTA, Tapas K, RICHARDS, Jon M, SAMLOWSKI, Wolfram E, COSTANZI, John J, ARONSON, Frederick R, DEISSEROTH, Albert B, DUDEK, Arkadiusz Z, JONES, Vicky E, THOMPSON, John A, KASHANI-SABET, Mohammed, DECONTI, Ronald C, HWU, Wen-Jen, ATKINS, Michael B, WHITMAN, Eric, ERNSTOFF, Marc S, HALUSKA, Frank G
Published in Journal of clinical oncology (20.05.2007)
Published in Journal of clinical oncology (20.05.2007)
Get full text
Journal Article
Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial
Cortes, Jorge E., Kim, Dong-Wook, Pinilla-Ibarz, Javier, le Coutre, Philipp D., Paquette, Ronald, Chuah, Charles, Nicolini, Franck E., Apperley, Jane F., Khoury, H. Jean, Talpaz, Moshe, DeAngelo, Daniel J., Abruzzese, Elisabetta, Rea, Delphine, Baccarani, Michele, Müller, Martin C., Gambacorti-Passerini, Carlo, Lustgarten, Stephanie, Rivera, Victor M., Haluska, Frank G., Guilhot, François, Deininger, Michael W., Hochhaus, Andreas, Hughes, Timothy P., Shah, Neil P., Kantarjian, Hagop M.
Published in Blood (26.07.2018)
Published in Blood (26.07.2018)
Get full text
Journal Article
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Kim, Dong-Wan, Tiseo, Marcello, Ahn, Myung-Ju, Reckamp, Karen L, Hansen, Karin Holmskov, Kim, Sang-We, Huber, Rudolf M, West, Howard L, Groen, Harry J M, Hochmair, Maximilian J, Leighl, Natasha B, Gettinger, Scott N, Langer, Corey J, Paz-Ares Rodríguez, Luis G, Smit, Egbert F, Kim, Edward S, Reichmann, William, Haluska, Frank G, Kerstein, David, Camidge, D Ross
Published in Journal of clinical oncology (01.08.2017)
Published in Journal of clinical oncology (01.08.2017)
Get full text
Journal Article
Impact of dose intensity of ponatinib on selected adverse events: multivariate analyses from a pooled population of clinical trial patients
Dorer, David J, Knickerbocker, Ronald K, Baccarani, Michele, Cortes, Jorge E, Hochhaus, Andreas, Talpaz, Moshe, Haluska, Frank G
Published in Leukemia research (01.09.2016)
Published in Leukemia research (01.09.2016)
Get full text
Journal Article
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
Lipton, Jeffrey H, Prof, Chuah, Charles, MD, Guerci-Bresler, Agnès, MD, Rosti, Gianantonio, Prof, Simpson, David, Prof, Assouline, Sarit, MD, Etienne, Gabriel, MD, Nicolini, Franck E, MD, le Coutre, Philipp, Prof, Clark, Richard E, Prof, Stenke, Leif, MD, Andorsky, David, MD, Oehler, Vivian, MD, Lustgarten, Stephanie, PhD, Rivera, Victor M, PhD, Clackson, Timothy, PhD, Haluska, Frank G, MD, Baccarani, Michele, Prof, Cortes, Jorge E, Prof, Guilhot, François, Prof, Hochhaus, Andreas, Prof, Hughes, Timothy, Prof, Kantarjian, Hagop M, Prof, Shah, Neil P, Prof, Talpaz, Moshe, Prof, Deininger, Michael W, Prof
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute
Katz, Kenneth A, Jonasch, Eric, Hodi, F Stephen, Soiffer, Robert, Kwitkiwski, Kimberly, Sober, Arthur J, Haluska, Frank G
Published in Melanoma research (01.02.2005)
Published in Melanoma research (01.02.2005)
Get more information
Journal Article